Cite
HARVARD Citation
Xu, X. et al. (2020). NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD‐L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy. Oncologist. pp. e955-e963. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, X. et al. (2020). NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD‐L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy. Oncologist. pp. e955-e963. [Online].